A week full of opportunities, where all your business objectives will have the chance to grow and progress with over 50,000 pharma professionals from 122 countries. 9 events in 1 week will take place across the city of Greater Noida, Delhi NCR, focusing on Business, Leadership, Knowledge, Innovation, Recognition & Networking in the field of Pharma. India Pharma Week returns in 2018: A week full of events alongside CPhI and P-MEC India as the seedbed of the growing Indian Pharma Industry.
Currently, India has 2,633 FDA-approved drug products. India became the third largest global generic API merchant market by 2016, with a 7.2 per cent market share. India contributes the second largest share of pharmaceutical and biotech workforce in the world. Generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally and it is expected to expand even further in the coming years. Indian pharmaceutical sector accounts for about 3.1 - 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms and is expected to grow to US$ 100 billion by 2025. In February 2018, the Indian pharmaceutical market grew at 7.1 per cent.
With 71 per cent market share, generic drugs form the largest segment of the Indian pharmaceutical sector. The 'Pharma Vision 2020' by the government's Department of Pharmaceuticals aims to make India a major hub for end-to-end drug discovery. The country accounts for the second largest number of Abbreviated New Drug Applications (ANDAs) and is the world's leader in Drug Master Files (DMFs) applications with the US Indian Drugs & Pharmaceuticals sector has received cumulative FDI worth US$ 15.59 billion between April 2000-December 2017.
Indian drugs are exported to more than 200 countries in the world, with the US as the key market. India exported pharmaceutical items worth US$ 16.84 billion in FY17 and US$ 10.76 billion during April 2017-January 2018.
The Government of India plans to set up a US$ 640 million venture capital fund to boost drug discovery and strengthen pharmaceutical infrastructure. India has over 546 USFDA-approved company sites, the highest number outside the US.
About CPhI & P-MEC India :
CPhI India is South Asia's leading pharma exhibitors displaying complete supply chain from drug discovery to finished dosage, manufacturers of API, Generics, Excipients and Drug formulation, Fine chemicals, Biosimilars, Finished formulations, Lab chemicals and Biotechnology.
P-MEC, on the other hand, includes manufacturers of Pharma Machinery and Equipment, Analytical Equipment, Packaging Machines & Packaging Consumables, Plant / Facility Equipment, Automation & Controls, Processing Equipment, RFID, Tableting / Capsule fillers, Clean room equipment, Filling equipment and Laboratory products.
About Us
Millenium Packaging Solutions is providing sales and service of Secondary Packaging Machines and Consumable from the last 2 decades. a “Market Driven” professional group in the field of “End Line Packaging”.
Company is engaged into Export, Manufacture and Distribution of Secondary Packaging Machines like Strapping Machine, Taping Machine, Vacuum Packaging Machine, Stretch Wrappers, Shrink Packaging Machines and it's consumables like Strapping Rolls, BOPP Tapes, PET STraps, Shrink Films, Stretch films.
